Research Impact

h-index

N/A

Research impact score

Publications

0

Total publications

Trial Results

0

Published trial results

Citations

0

Total citations

Drug Portfolio

Analytics

Trial Phases

Phase 15
Phase 25

Trial Status

Completed6
Terminated3
Other2

Role Distribution

Principal Investigator11
PI Rate100%

Activity Timeline

Clinical Trials (11)

NCT04721743Withdrawn
Microbiome as a ThErapeutic Response Biomarker
Uveitis
PrincipalinvestigatorStart date: 2021-05-03
NCT02911116Phase 2Completed
Ustekinumab (STELARA) for the Treatment of Active Sight-Threatening Uveitis (STAR Study)
Uveitis
PrincipalinvestigatorStart date: 2017-03-30
NCT00539370Terminated
Human Samples and Data Repository
ScleritisUveitis
PrincipalinvestigatorStart date: 2007-08-29
NCT00647439Completed
Genetics and Markers of Degenerative and Inflammatory Eye Diseases
Age-Related Macular Degeneration (AMD)Diabetic RetinopathyUveitis
Principalinvestigator
NCT01086631Phase 1Completed
Rituximab for Autoimmune Retinopathy
Autoimmune Disease
Principalinvestigator
NCT01109433Terminated
Immunogenetic Mechanisms in Behcet's Disease
Behcet's DiseaseUveitis
Principalinvestigator
NCT01314417Phase 1/2Terminated
Treatment of Non-infectious Intermediate and Posterior Uveitis Associated Macular Edema With Intravitreal Methotrexate
Non-infectious Intermediate and Posterior Uveitis
Principalinvestigator
NCT01517074Phase 1/2Completed
Sirolimus Injections for Autoimmune Scleritis
Scleritis
Principalinvestigator
NCT01647152Phase 1/2Withdrawn
Ustekinumab for Active Sight-Threatening Uveitis
Uveitis
Principalinvestigator

Showing 10 of 11 trials

Research Network

Collaboration Network

1 collaborators·0 connections
Network Legend
KOL
Current Investigator
CO
High-influence Collaborator
CO
Collaborator
Click: view details
Double-click: go to profile
Drag: move node

Similar Key Opinion Leaders

Discover other key opinion leaders with similar research profiles, therapeutic areas, and collaboration networks.

10 similar investigators found

Publications (0)

No publications found for this investigator.

Clinical Trials (11)

Showing 11 of 11 trials

NCT04721743PrincipalInvestigator

Microbiome as a ThErapeutic Response Biomarker

Uveitis
Withdrawn
NCT02911116Phase 2PrincipalInvestigator

Ustekinumab (STELARA) for the Treatment of Active Sight-Threatening Uveitis (STAR Study)

Uveitis
Completed
NCT00539370PrincipalInvestigator

Human Samples and Data Repository

ScleritisUveitis
Terminated
NCT00357071PrincipalInvestigator

Immune Responses to Antigens in Non-infectious Eye Inflammatory Diseases

Eye Diseases
Completed
NCT00647439PrincipalInvestigator

Genetics and Markers of Degenerative and Inflammatory Eye Diseases

Age-Related Macular Degeneration (AMD)Diabetic RetinopathyUveitis
Completed
NCT01086631Phase 1PrincipalInvestigator

Rituximab for Autoimmune Retinopathy

Autoimmune Disease
Completed
NCT01109433PrincipalInvestigator

Immunogenetic Mechanisms in Behcet's Disease

Behcet's DiseaseUveitis
Terminated
NCT01314417Phase 1/2PrincipalInvestigator

Treatment of Non-infectious Intermediate and Posterior Uveitis Associated Macular Edema With Intravitreal Methotrexate

Non-infectious Intermediate and Posterior Uveitis
Terminated
NCT01517074Phase 1/2PrincipalInvestigator

Sirolimus Injections for Autoimmune Scleritis

Scleritis
Completed
NCT01647152Phase 1/2PrincipalInvestigator

Ustekinumab for Active Sight-Threatening Uveitis

Uveitis
Withdrawn
NCT01835132Phase 1/2PrincipalInvestigator

Gevokizumab for Active Scleritis

Scleritis
Completed

All 11 trials loaded